Hyodo et al reported the Japanese Palliative Oncology Study Prognostic Index (JPOS-PI). This can help to stratify patients with a terminal cancer. The authors are from Tsukuba University, Shizuoka Cancer Center, Kanamecho Hospital (Tokyo) and the National Cancer Center Hospital East (Chiba) in Japan.
Patient selection: terminal cancer
Parameters:
(1) physician’s prediction of survival in weeks (clinical prediction of survival , CPS)
(2) level of consciousness
(3) pleural effusion
(4) WBC count
(5) percent lymphocytes in the differential count on the peripheral blood
|
Parameter |
Finding |
Points |
|
physician’s prediction |
<= 2 weeks |
6.5 |
|
|
3 or 4 weeks |
3 |
|
|
5 or 6 weeks |
2 |
|
|
>= 7 weeks |
0 |
|
consciousness |
clear |
0 |
|
|
clouded (not clear) |
1.5 |
|
pleural effusion |
none or mild |
0 |
|
|
moderate or severe |
1.5 |
|
WBC count |
< 10,000 per µL |
0 |
|
|
>= 10,000 per µL |
1.5 |
|
percent lymphocytes |
< 20% |
2 |
|
|
>= 20% |
0 |
total score =
= SUM(points for all 5 parameters)
Interpretation:
• minimum score: 0
• maximum score: 13
• The higher the score the greater the risk.
|
Total Score |
Risk Group |
Percent Surviving > 30 Days |
|
<= 3 |
low |
80% |
|
3.5 to 5.5 |
intermediate |
50 – 60% |
|
>= 6 |
high |
11 – 16% |
Purpose: To evaluate a patient with terminal cancer using the Japan Palliative Oncology Study-Prognostic Index (JPOS-PI).
Specialty: Hematology Oncology, Surgery, general
Objective: severity, prognosis, stage, end-of-life, palliative care
ICD-10: C00-C14, C15-C26, C30-C39, C40-C41, C43-C44, C45-C49, C50-C50, C51-C58, C60-C63, C64-C68, C69-C72, C73-C75, C76-C80, C81-C96, C97-C97, Z51.5,
